These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 20890584

  • 21. [Epithelial-mesenchymal transition and colon cancer].
    Scoazec JY.
    Ann Pathol; 2009 Nov; 29 Spec No 1():S63-4. PubMed ID: 19887255
    [No Abstract] [Full Text] [Related]

  • 22. Transforming growth factor beta1 treatment leads to an epithelial-mesenchymal transdifferentiation of pancreatic cancer cells requiring extracellular signal-regulated kinase 2 activation.
    Ellenrieder V, Hendler SF, Boeck W, Seufferlein T, Menke A, Ruhland C, Adler G, Gress TM.
    Cancer Res; 2001 May 15; 61(10):4222-8. PubMed ID: 11358848
    [Abstract] [Full Text] [Related]

  • 23. Loss of type III transforming growth factor beta receptor expression increases motility and invasiveness associated with epithelial to mesenchymal transition during pancreatic cancer progression.
    Gordon KJ, Dong M, Chislock EM, Fields TA, Blobe GC.
    Carcinogenesis; 2008 Feb 15; 29(2):252-62. PubMed ID: 17999987
    [Abstract] [Full Text] [Related]

  • 24. MEG8 long noncoding RNA contributes to epigenetic progression of the epithelial-mesenchymal transition of lung and pancreatic cancer cells.
    Terashima M, Ishimura A, Wanna-Udom S, Suzuki T.
    J Biol Chem; 2018 Nov 23; 293(47):18016-18030. PubMed ID: 30262664
    [Abstract] [Full Text] [Related]

  • 25. TGF-beta-induced epithelial to mesenchymal transition.
    Xu J, Lamouille S, Derynck R.
    Cell Res; 2009 Feb 23; 19(2):156-72. PubMed ID: 19153598
    [Abstract] [Full Text] [Related]

  • 26. N-cadherin expression and epithelial-mesenchymal transition in pancreatic carcinoma.
    Nakajima S, Doi R, Toyoda E, Tsuji S, Wada M, Koizumi M, Tulachan SS, Ito D, Kami K, Mori T, Kawaguchi Y, Fujimoto K, Hosotani R, Imamura M.
    Clin Cancer Res; 2004 Jun 15; 10(12 Pt 1):4125-33. PubMed ID: 15217949
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Thymidylate synthase is functionally associated with ZEB1 and contributes to the epithelial-to-mesenchymal transition of cancer cells.
    Siddiqui A, Vazakidou ME, Schwab A, Napoli F, Fernandez-Molina C, Rapa I, Stemmler MP, Volante M, Brabletz T, Ceppi P.
    J Pathol; 2017 Jun 15; 242(2):221-233. PubMed ID: 28337746
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. TMEPAI regulates EMT in lung cancer cells by modulating the ROS and IRS-1 signaling pathways.
    Hu Y, He K, Wang D, Yuan X, Liu Y, Ji H, Song J.
    Carcinogenesis; 2013 Aug 15; 34(8):1764-72. PubMed ID: 23615405
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Loss of FOXA1/2 is essential for the epithelial-to-mesenchymal transition in pancreatic cancer.
    Song Y, Washington MK, Crawford HC.
    Cancer Res; 2010 Mar 01; 70(5):2115-25. PubMed ID: 20160041
    [Abstract] [Full Text] [Related]

  • 37. Vitamin D receptor signaling and pancreatic cancer cell EMT.
    Li Z, Guo J, Xie K, Zheng S.
    Curr Pharm Des; 2015 Mar 01; 21(10):1262-7. PubMed ID: 25506892
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.